Published in Pharmacotherapy on October 09, 1986
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med (2000) 10.25
Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA (1998) 4.48
Alternatives to lithium for preventive treatment of bipolar disorder. Am J Psychiatry (1989) 3.32
Injection site reactions after intramuscular administration of haloperidol decanoate 100 mg/mL. J Clin Psychiatry (1990) 3.22
The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther (2000) 3.07
Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry (2000) 2.70
A practical update on anxiety disorders and their pharmacologic treatment. Arch Intern Med (1991) 2.21
The catatonic syndrome. Lancet (1976) 1.82
Primary cardiac tumours in childhood. Arch Dis Child (1971) 1.70
Psychiatric applications of bromocriptine therapy. J Clin Psychiatry (1990) 1.61
Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry (2000) 1.61
Gender differences in chronic major and double depression. J Affect Disord (2000) 1.53
A review of 32 cases of tardive dystonia. Am J Psychiatry (1991) 1.45
Serum lithium levels and psychosocial function in patients with bipolar I disorder. Am J Psychiatry (1996) 1.42
Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium. Arch Gen Psychiatry (1992) 1.40
Possible influence of carbamazepine on plasma imipramine concentrations in children with attention deficit hyperactivity disorder. J Clin Psychopharmacol (1990) 1.38
Lost human capital from early-onset chronic depression. Am J Psychiatry (2000) 1.25
Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients. J Clin Psychiatry (1989) 1.23
Lecithin can suppress tardive dyskinesia. N Engl J Med (1978) 1.14
Pharmacologic treatment of depression during pregnancy. JAMA (1999) 1.12
Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand (2006) 1.10
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. J Clin Psychiatry (1998) 1.05
Citalopram as adjunctive therapy in bipolar depression. J Clin Psychiatry (2001) 1.02
Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. Am J Psychiatry (1979) 0.97
Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. Psychopharmacol Bull (1993) 0.96
Catatonic reactions to high-potency neuroleptic drugs. Arch Gen Psychiatry (1977) 0.96
A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness. Psychopharmacology (Berl) (1979) 0.95
Tryptophan depletion and depressive vulnerability. Biol Psychiatry (1999) 0.93
Factors associated with the elderly falling in intermediate care facilities. Drug Intell Clin Pharm (1985) 0.92
Sertraline versus imipramine to prevent relapse in chronic depression. J Affect Disord (2001) 0.92
The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. J Clin Psychiatry (1998) 0.90
Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics. Arch Gen Psychiatry (1982) 0.90
Fluoxetine/norfluoxetine concentrations in human milk. Pediatrics (1992) 0.88
Munchausen's syndrome with a psychiatric presentation. Dis Nerv Syst (1977) 0.88
Pregnancy, psychotropic drugs, and psychiatric disorders. Psychosomatics (1986) 0.85
Diltiazem for tardive dyskinesia and tardive dystonia. Lancet (1988) 0.84
Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study. J Clin Psychiatry (1979) 0.84
Amoxapine--an antidepressant with some neuroleptic properties? A review of its chemistry, animal pharmacology and toxicology, human pharmacology, and clinical efficacy. Pharmacotherapy (1986) 0.84
Thermodilution measurement of left and right ventricular outputs. Cardiovasc Res (1971) 0.84
Treating extrapyramidal reactions: some current issues. J Clin Psychiatry (1987) 0.83
Pindolol augmentation of treatment-resistant depressed patients. J Clin Psychiatry (1997) 0.82
The amobarbital interview. Mil Med (1980) 0.82
Serum lithium levels and the outcome of maintenance therapy of bipolar disorder. Bipolar Disord (2000) 0.82
Prevalence of tardive dyskinesia in an outpatient population. Compr Psychiatry (1980) 0.82
Neurotransmitter precursors for the treatment of depression. Psychopharmacol Bull (1982) 0.81
Double-blind comparison of amoxapine and imipramine in the treatment of depressed patients. J Clin Psychiatry (1984) 0.80
Sexual dysfunction secondary to depressive disorders. J Gend Specif Med (2001) 0.80
Psychiatric pharmacy practice specialty certification process. Am J Health Syst Pharm (1998) 0.80
An evaluation of population pharmacokinetics in therapeutic trials. Part II. Detection of a drug-drug interaction. Clin Pharmacol Ther (1987) 0.79
Amitriptyline, clovoxamine and cognitive function: a placebo-controlled comparison in depressed outpatients. Psychopharmacology (Berl) (1992) 0.79
Choline and lecithin administration to patients with tardive dyskinesia. Trans Am Neurol Assoc (1978) 0.79
Tyrosine for the treatment of depression. Am J Psychiatry (1980) 0.79
L-tyrosine in depression. Lancet (1980) 0.78
Effects of two antidepressants on memory performance in depressed outpatients: a double-blind study. Psychopharmacology (Berl) (1984) 0.78
Bipolar disorder in women: reproductive events and treatment considerations. Acta Psychiatr Scand (2005) 0.78
Evaluating the impact of education by a clinical pharmacist on antibiotic prescribing and administration in an acute care state psychiatric hospital. Hosp Pharm (1986) 0.78
Criteria for the diagnosis of catatonia. Am J Psychiatry (1977) 0.78
The effect of dantrolene sodium on spasticity in multiple sclerosis. Neurology (1973) 0.78
Seizure activity associated with antipsychotic therapy. DICP (1990) 0.78
The effect of ranitidine and cimetidine on imipramine disposition. Eur J Clin Pharmacol (1986) 0.77
Renal function monitoring in patients receiving lithium carbonate. J Clin Psychiatry (1981) 0.77
Computerized tomography in patients with tardive dyskinesia. Am J Psychiatry (1976) 0.77
Effects of lithium on the kidney. Acta Psychiatr Scand (1987) 0.77
Unusual lymphocyte subset distribution in some depressed patients. J Clin Psychiatry (1990) 0.76
Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate. Am J Psychiatry (1979) 0.76
Alpha 2-adrenergic receptors in platelet membranes of depressed patients: increased affinity for 3H-yohimbine. Psychiatry Res (1987) 0.76
General principles of treatment of extrapyramidal syndromes. Clin Neuropharmacol (1983) 0.76
Interactions between antipsychotic and antihypertensive drugs. Ann Pharmacother (1995) 0.76
The pharmacologic treatment of schizophrenia: a progress report. Schizophr Bull (1983) 0.76
Tyrosine for the treatment of depression. Nutr Health (1984) 0.76
Knowing our limits. Acta Psychiatr Scand (1998) 0.75
Major complications of neuroleptic drug use. West J Med (1994) 0.75
Alpha 2-adrenergic receptor sensitivity in depressed patients: relation between 3H-yohimbine binding to platelet membranes and clonidine-induced hypotension. Biol Psychiatry (1989) 0.75
Antidepressants in the general hospital. Can Med Assoc J (1979) 0.75
Editorial statement. Acta Psychiatr Scand (1995) 0.75
Anticholinergic psychosis in a patient receiving usual doses of haloperidol, desipramine, and benztropine. Clin Pharm (1983) 0.75
Single case study. Amoxapine, a new antidepressant, appears in human milk. J Nerv Ment Dis (1979) 0.75
Depression, depressants, and antidepressants. Arch Intern Med (1990) 0.75
The effect of amoxapine and imipramine on serum prolactin levels. Arch Intern Med (1981) 0.75
Open-label sildenafil treatment of partial and non-responders to double-blind treatment in men with antidepressant-associated sexual dysfunction. Int J Impot Res (2006) 0.75
Nutrition in psychiatry: we are what we eat? J Clin Psychiatry (1980) 0.75
Pharmacologic management of acute mania in pregnancy. J Clin Psychopharmacol (1989) 0.75
Pharmacologic treatment of depressive subtypes. Psychiatr Med (1988) 0.75
Can lithium help to prevent suicide? Acta Psychiatr Scand (2001) 0.75
Imperfect drugs in an imperfect world. J Clin Psychiatry (1992) 0.75
A double-blind comparison of clovoxamine and amitriptyline in the treatment of depressed outpatients. J Clin Psychopharmacol (1985) 0.75
Psychiatry in the 1990s. J Clin Psychiatry (1991) 0.75
Psychiatry 2013. J Clin Psychiatry (1993) 0.75
Using physostigmine safely. Am J Psychiatry (1979) 0.75
If not now, when? J Clin Psychiatry (1992) 0.75
Amoxapine for the treatment of psychotically depressed subjects. A pilot study. J Nerv Ment Dis (1985) 0.75
Ergoloid mesylates and ECT. J Clin Psychiatry (1989) 0.75
The effects of amitriptyline and lithium on a patient with 48-hour recurrent depressions. J Nerv Ment Dis (1978) 0.75
Antidepressants: their use in clinical practice. Ration Drug Ther (1978) 0.75
Using a drug audit program to reduce polypharmacy in a state psychiatric hospital. Hosp Community Psychiatry (1986) 0.75
Treating the outpatient schizophrenic. Postgrad Med (1978) 0.75
Cardiac arrhythmias after psychotropic drugs. Am J Cardiol (1977) 0.75
An open trial of maprotiline for the treatment of cocaine abuse: a pilot study. J Clin Psychopharmacol (1988) 0.75
Recurrent unipolar depressions with a 48-hour cycle: report of a case. Br J Psychiatry (1978) 0.75
Use of choline and lecithin in the treatment of tardive dyskinesia. Adv Biochem Psychopharmacol (1980) 0.75